TMS for PTSD

Sam Clinch • July 4, 2022

As we celebrate our nation’s independence on July 4th, we must also take time to recognize those who fought, and continue to fight, for our freedom, to acknowledge the sacrifices they have made, and oftentimes, the trauma they have endured as a result. 

According to the U.S. Department of Veterans Affairs, depending on the service area, anywhere from 11 to 30% of Veterans have suffered or continue to suffer from posttraumatic stress disorder (PTSD) (  https://www.ptsd.va.gov/understand/common/common_veterans.asp). Additionally, a 2020 survey found that 83% of all U.S. veterans as well as active duty service members have experienced PTSD since the 9/11 attack, as a result of their military service (  https://www.cumberlandheights.org/blogs/ptsd-statistics-veterans/ ). 

While PTSD is most often associated with war veterans, especially those who have experienced combat, it can develop in anyone who has been exposed to a traumatic event, both directly and indirectly. The National Center for PTSD (part of the U.S. Department of Veterans Affairs) estimates that between 7 and 8% of the U.S. population will experience PTSD at some point in their lifetime, and around 8 million adults are suffering from PTSD in a given year (  How Common is PTSD in Adults? - PTSD: National Center for PTSD (va.gov)  ). 

The most common forms of treatment for PTSD, like many other mental health conditions, are medications and psychotherapy. However, what options are available for patients who do not respond to these prevailing forms of treatment? A recent meta-analysis showed that less than half of patients receiving trauma focused therapy achieved a meaningful response to treatment, some two-thirds of patients failed to achieve remission, and one-third dropped out of treatment. And the effect size for medications was even less than for therapy (Transcranial magnetic stimulation for post-traumatic stress disorder (nih.gov)). Other treatment methods primarily include electroconvulsive therapy (ECT), with some developing investigation into substances such as ketamine, or esketamine, and psilocybin for the treatment of PTSD. Nevertheless, these courses of therapy often carry significant risks or side effects. ECT involves risks associated with anesthesia as well as short-term memory impairments, and substances like ketamine and psilocybin raise concerns about abuse potential and long-term effectiveness.


All hope is not lost, however. While often overlooked and underutilized, repetitive transcranial magnetic stimulation, or rTMS, is proving to be a revolutionary treatment modality for many psychiatric disorders, including PTSD. Initially FDA approved for the treatment of pharmacoresistant major depressive disorder (MDD), TMS is an evidence-based treatment that holds minimal safety risks and involves no systemic side effects. Research regarding TMS therapy is ongoing, and now has been shown to be effective not only in the treatment of MDD, but also for anxiety, obsessive-compulsive disorder, smoking cessation,  bipolar depression, and PTSD. 

Numerous studies have shown TMS to be an effective treatment option for PTSD when medications and therapy have not worked. In 2021, the VA implemented a nationwide study to evaluate clinical outcomes in veterans being treated with TMS  . While the primary inclusion criteria for this study was MDD, around 68% of the patients in this study also suffered from comorbid PTSD, and both MDD and PTSD responses were measured. Of the 340 veterans who received an adequate dose of TMS, 41.4% showed response and 20% showed remission related to MDD. Additionally, in veterans with comorbid PTSD, 65.3% showed response and 46.1% no longer met threshold criteria after receiving an adequate dose of TMS (  https://www.sciencedirect.com/science/article/pii/S0165032721011022  ). 

Different protocols have been utilized in an attempt to treat the core symptoms of PTSD, but most, similar to depression treatment, also target an area of the brain called the dorsolateral prefrontal cortex. Some studies have utilized as few as 10 treatments in two weeks and found this to be beneficial, but more sessions and more pulses per session tended to show greater improvement in symptoms. Longer term response data is more limited, but points to at least 2-3 months of sustained response following treatment and a more recent paper has found benefit with TMS up to 1 year post treatment (One-year clinical outcomes following theta burst stimulation for post-traumatic stress disorder (nih.gov)  ). 

For more details regarding further studies and results of TMS for PTSD, head to our page all about   TMS for PTSD   . If you or someone you know is struggling with PTSD and haven’t seen results from traditional forms of treatment, like medications or therapy, TMS may be the right choice. Set up a free phone consultation   with our doctor to find out more about how TMS can treat PTSD.

Every Question Answered

Want to know more about TMS? Check out this in-depth guide to TMS therapy with transparent and easy to understand explanations about TMS processes, protocols, and treated conditions.

Latest Posts

By Sam Clinch December 13, 2025
Quick summary (the short answers) Medicare: Often covers TMS for treatment-resistant major depressive disorder when the plan’s clinical criteria (such as prior medication trials) are met and prior authorization is approved. Inspire routinely helps patients with Medicare benefits checks and authorizations. Medicaid: Coverage varies by state . Some state Medicaid plans cover TMS with strict medical necessity criteria; others do not. Inspire collects your insurance details and runs a state-specific benefits check. Pre-authorization: Nearly always required. Insurers want documented prior treatment attempts, objective symptom measures (PHQ-9), and a psychiatrist’s letter of medical necessity. Inspire will run the authorization for you once you approve.
By Sam Clinch December 12, 2025
What Inspire TMS Denver accepts and what that means In-network / insurer relationships: Inspire states it accepts major commercial insurers and works with patients to obtain coverage - including Medicare and Tricare, where criteria are met - and the clinic routinely runs benefits checks and prior authorizations on a patient’s behalf. That means you don’t need to guess whether a policy will pay - Inspire will verify for you. Common Medicare / commercial rules (examples): Different payers have specific clinical criteria. For example (from the clinic’s pricing documents): Anthem - typically requires failure of two different antidepressants from different classes (or intolerance). Medicare -may require failure of one previous antidepressant (or intolerance) Tricare - covers TMS when it is medically necessary and prior less-intensive interventions have failed or are inappropriate. These examples illustrate typical insurer frameworks, but your plan may differ. What’s often covered vs not covered: Commonly covered: FDA-cleared TMS for treatment-resistant major depressive disorder when prior treatment criteria are met and prior authorization is approved. Often not covered (or considered “off-label”): accelerated TMS protocols , certain indications (some anxiety/insomnia/experimental uses), and some PTSD/anxiety uses; these may require self-pay or sliding-scale payment. Inspire notes it offers sliding-scale/self-pay for off-label care and for financial hardship.
By Sam Clinch December 12, 2025
How TMS is different: a quick, plain-language explanation TMS uses a magnetic coil to stimulate specific areas of the brain associated with mood and emotional control. It’s non-invasive, does not require anesthesia, and is performed in an outpatient setting. Instead of changing chemistry like antidepressants or providing a rapid but medication-based reset like ketamine , TMS aims to retrain brain circuits by repeatedly activating under-performing regions so they function more normally over time. Inspire’s patient materials stress this neuroplastic, circuit-based approach and describe mapping, stimulation and physician oversight used to personalize treatment.
By Sam Clinch December 11, 2025
What is “treatment-resistant depression” (TRD)? Clinically, TRD is commonly defined as depression that has not sufficiently responded to an adequate trial of two different antidepressants (from at least two different classes) given at therapeutic doses and durations. Some insurers and clinical guidelines use this “two-trial” rule when deciding whether to cover advanced treatments like TMS. Medicare and commercial payers may have slightly different wording (for example, Medicare sometimes requires one failed antidepressant; Anthem often requires two). The key idea is consistent: TRD means standard medication strategies haven’t produced an acceptable response.
By Sam Clinch December 10, 2025
Your main options while you’re in Colorado Short/accelerated courses If you have very limited time, accelerated TMS (iTBS or compressed protocols) lets clinics deliver many sessions over a few days rather than weeks. Inspire offers accelerated regimens (MagVenture-capable) and lists accelerated TMS as an option for patients who need a fast course, but note: accelerated courses are often not covered by insurance and usually require self-pay or sliding-scale arrangements. Maintenance or “rescue” sessions Maintenance or “rescue” sessions If you’ve completed a full course and need occasional boosters to maintain gains while away, maintenance TMS (weekly, biweekly, or monthly sessions) is common. Clinics also provide rescue or extension courses when symptoms re-emerge. Maintenance often requires a clinician discussion to set frequency, and many insurers do not routinely cover maintenance so clinics may offer packages or discounted session bundles. Full course continuation If your original acute course was interrupted, many clinics will pick up or adjust your plan; this typically requires review of previous mapping and progress measures and coordination with your home TMS provider. Inspire performs mapping and tailors plans to each patient’s needs.
Soldiers in uniform seated in a circle; one person comforts another, all in a support group setting.
By Sam Clinch December 9, 2025
Short answer: Yes — Transcranial Magnetic Stimulation (TMS) is increasingly used to treat PTSD symptoms, and many patients report improvements in intrusive memories (flashbacks), hypervigilance and reactivity. At Inspire TMS Denver we tailor TMS protocols to each person’s needs and monitor results closely, offering standard and advanced TMS options for trauma-related symptoms.
Woman in blue scrubs smiles in front of an
By Sam Clinch December 9, 2025
Who is this page for? If you’re searching “ TMS therapy near me ” because medications or therapy haven’t worked, this guide walks you through what TMS is, the types of TMS offered at Inspire TMS Denver, who qualifies, what a typical course looks like, cost & insurance realities, and real patient experiences so you can decide whether to book a free consultation. Inspire is a doctor-led clinic that specializes in evidence-based TMS and personalized care.
By Sam Clinch November 20, 2025
Recognizing the Signs of Bipolar Disorder Bipolar disorder is often misunderstood or misdiagnosed due to its fluctuating nature. Common signs include: Periods of extreme energy or euphoria (mania or hypomania) Sudden shifts to sadness, fatigue, or hopelessness (depression) Difficulty concentrating or making decisions Sleep disturbances (sleeping too much or too little) Impulsive or risky behavior Feelings of irritability or agitation  While everyone experiences mood shifts occasionally, those with bipolar disorder often find these changes disruptive to work, relationships, and daily life.
By Leo Cook November 18, 2025
If you’re struggling with depression, you’re not alone - and you’re likely asking: What actually works? That’s where TMS (Transcranial Magnetic Stimulation) enters the conversation. Let’s break down how effective TMS really is - nationally and here at Inspire TMS Denver .
By Sam Clinch November 18, 2025
Understand Eligibility, Insurance, and Whether TMS Might Be Right for You
Show More